In 2023, the Center for Drug Evaluation of the National Medical Products Administration (NMPA) in China received 2,168 applications for approval of biopharmaceuticals. The figure increased substantially from the previous years, and represented more than 20 percent of all applications received by the governing body. Examples of biopharmaceuticals include vaccines, blood products, and "living medicine" used in cell therapy.
Number of applications for approval of biological medical products subjected to technical reviews in China from 2018 to 2023
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
National Medical Products Administration. (April 2, 2024). Number of applications for approval of biological medical products subjected to technical reviews in China from 2018 to 2023 [Graph]. In Statista. Retrieved November 13, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1319688/china-number-of-biopharmaceutical-evaluation-applications-submitted/
National Medical Products Administration. "Number of applications for approval of biological medical products subjected to technical reviews in China from 2018 to 2023." Chart. April 2, 2024. Statista. Accessed November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1319688/china-number-of-biopharmaceutical-evaluation-applications-submitted/
National Medical Products Administration. (2024). Number of applications for approval of biological medical products subjected to technical reviews in China from 2018 to 2023. Statista. Statista Inc.. Accessed: November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1319688/china-number-of-biopharmaceutical-evaluation-applications-submitted/
National Medical Products Administration. "Number of Applications for Approval of Biological Medical Products Subjected to Technical Reviews in China from 2018 to 2023." Statista, Statista Inc., 2 Apr 2024, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1319688/china-number-of-biopharmaceutical-evaluation-applications-submitted/
National Medical Products Administration, Number of applications for approval of biological medical products subjected to technical reviews in China from 2018 to 2023 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1319688/china-number-of-biopharmaceutical-evaluation-applications-submitted/ (last visited November 13, 2024)
Number of applications for approval of biological medical products subjected to technical reviews in China from 2018 to 2023 [Graph], National Medical Products Administration, April 2, 2024. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1319688/china-number-of-biopharmaceutical-evaluation-applications-submitted/
